The cell biology technology provider, which counts Nikon and Varian Medical among its investors, has raised about $215m in venture funding.

Wuxi AppTec and Pfizer have both contributed as the Yale University-founded cancer drug developer prepares for clinical testing next year.

SR One and Roche Venture Fund-backed Pandion Therapeutics will use the proceeds from the offering to advance a lead drug candidate for ulcerative colitis.

1868 Ventures will fund agriculture, lawncare and sustainable packaging technology developers, providing up to $2.5m for a first investment.

The hospitality data software provider received series B cash from Providence Strategic Growth to add to earlier funding from backers including Comcast and Amazon.

Wuxi AppTec and Pfizer contributed to a series A round that will support progress of Simcha Therapeutics' immuno-oncology treatments toward clinical trials.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Facit exited McMaster University's cancer radiotherapy spinout in an upsized initial public offering after $158m in funding.

The corporate has donated $200,000 to bring University of Michigan philanthropic seed fund Accelerate Blue halfway toward its $2m initial target.

The health insurance provider pushed its overall funding past $1.5bn in a late-stage round that included long-term investor Alphabet.